$206 Million is the total value of Worth Venture Partners, LLC's 101 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SOUTHWEST AIRLS COnote 1.250% 5/0 | $6,134,000 | – | 3,562,000 | +100.0% | 2.97% | – | |
| TLND | New | TALEND S Aads | $4,188,000 | – | 65,800 | +100.0% | 2.03% | – |
| New | AMERICAN AIRLS GROUP INCnote 6.500% 7/0 | $3,529,000 | – | 2,050,000 | +100.0% | 1.71% | – | |
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $3,397,000 | – | 2,584,000 | +100.0% | 1.65% | – | |
| New | ALLSCRIPTS HEALTHCARE SOLUTNnote 0.875% 1/0 | $3,305,000 | – | 2,494,000 | +100.0% | 1.60% | – | |
| New | ON SEMICONDUCTOR CORPnote 1.625%10/1 | $3,271,000 | – | 1,568,000 | +100.0% | 1.59% | – | |
| DZSI | New | DZS INC | $2,645,000 | – | 170,118 | +100.0% | 1.28% | – |
| RMNI | New | RIMINI STR INC DEL | $2,490,000 | – | 277,555 | +100.0% | 1.21% | – |
| New | LUMENTUM HLDGS INCnote 0.250% 3/1 | $2,447,000 | – | 1,512,000 | +100.0% | 1.19% | – | |
| New | ILLUMINA INCnote 0.500% 6/1 | $2,284,000 | – | 1,514,000 | +100.0% | 1.11% | – | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $2,204,000 | – | 226,758 | +100.0% | 1.07% | – |
| NVVE | New | NUVVE HOLDING ORD | $1,931,000 | – | 202,720 | +100.0% | 0.94% | – |
| GRTX | New | GALERA THERAPEUTICS INC | $1,890,000 | – | 214,242 | +100.0% | 0.92% | – |
| New | TWITTER INCnote 1.000% 9/1 | $1,759,000 | – | 1,692,000 | +100.0% | 0.85% | – | |
| BWAY | New | BRAINSWAY LTDsponsored ads | $1,613,000 | – | 178,600 | +100.0% | 0.78% | – |
| CDLX | New | CARDLYTICS INC | $1,550,000 | – | 14,130 | +100.0% | 0.75% | – |
| New | ISHARES TRput | $1,537,000 | – | 164,900 | +100.0% | 0.74% | – | |
| CVNA | New | CARVANA COcl a | $1,360,000 | – | 5,183 | +100.0% | 0.66% | – |
| OMF | New | ONEMAIN HLDGS INC | $1,312,000 | – | 24,431 | +100.0% | 0.64% | – |
| HOME | New | AT HOME GROUP INC | $1,260,000 | – | 43,899 | +100.0% | 0.61% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $1,250,000 | – | 387,141 | +100.0% | 0.61% | – |
| RJF | New | RAYMOND JAMES FINL INC | $1,187,000 | – | 9,688 | +100.0% | 0.58% | – |
| YTEN | New | YIELD10 BIOSCIENCE INC | $1,120,000 | – | 89,300 | +100.0% | 0.54% | – |
| New | ENVESTNET INCnote 1.750% 6/0 | $983,000 | – | 804,000 | +100.0% | 0.48% | – | |
| PCSA | New | PROCESSA PHARMACEUTICALS INC | $942,000 | – | 90,968 | +100.0% | 0.46% | – |
| MCHP | New | MICROCHIP TECHNOLOGY INC. | $881,000 | – | 5,679 | +100.0% | 0.43% | – |
| ENV | New | ENVESTNET INC | $847,000 | – | 11,728 | +100.0% | 0.41% | – |
| MDNA | New | MEDICENNA THERAPEUTICS CORP | $807,000 | – | 197,900 | +100.0% | 0.39% | – |
| FC | New | FRANKLIN COVEY CO | $803,000 | – | 28,379 | +100.0% | 0.39% | – |
| BAC | New | BK OF AMERICA CORP | $744,000 | – | 19,229 | +100.0% | 0.36% | – |
| New | CHF SOLUTIONS INC | $697,000 | – | 118,000 | +100.0% | 0.34% | – | |
| NVVEW | New | NUVVE HOLDING CORP*w exp 03/19/202 | $694,000 | – | 385,168 | +100.0% | 0.34% | – |
| HJLI | New | HANCOCK JAFFE LABORATORIES I | $671,000 | – | 100,714 | +100.0% | 0.32% | – |
| EVOK | New | EVOKE PHARMA INC | $616,000 | – | 336,516 | +100.0% | 0.30% | – |
| EXFO | New | EXFO INC | $527,000 | – | 123,732 | +100.0% | 0.26% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $515,000 | – | 6,820 | +100.0% | 0.25% | – |
| WFC | New | WELLS FARGO CO NEW | $505,000 | – | 12,938 | +100.0% | 0.24% | – |
| HSDT | New | HELIUS MED TECHNOLOGIES INC | $428,000 | – | 23,785 | +100.0% | 0.21% | – |
| PGR | New | PROGRESSIVE CORP | $339,000 | – | 3,546 | +100.0% | 0.16% | – |
| CTO | New | CTO REALTY GROWTH INC | $315,000 | – | 6,055 | +100.0% | 0.15% | – |
| HTGM | New | HTG MOLECULAR DIAGNOSTICS IN | $299,000 | – | 54,747 | +100.0% | 0.14% | – |
| COLD | New | AMERICOLD RLTY TR | $260,000 | – | 6,750 | +100.0% | 0.13% | – |
| GANX | New | GAIN THERAPEUTICS INC | $232,000 | – | 15,532 | +100.0% | 0.11% | – |
| QTS | New | QTS RLTY TR INC | $219,000 | – | 3,525 | +100.0% | 0.11% | – |
| New | AVAYA HLDGS CORPcall | $208,000 | – | 70,500 | +100.0% | 0.10% | – | |
| NLSPW | New | NLS PHARMACEUTICS EQY LTD*w exp 09/25/202 | $185,000 | – | 194,560 | +100.0% | 0.09% | – |
| BLIN | New | BRIDGELINE DIGITAL INC | $120,000 | – | 41,693 | +100.0% | 0.06% | – |
| EYEN | New | EYENOVIA INC | $96,000 | – | 18,833 | +100.0% | 0.05% | – |
| New | INVESCO EXCHANGE TRADED FD Tput | $89,000 | – | 23,500 | +100.0% | 0.04% | – | |
| New | AMERICAN AIRLS GROUP INCput | $33,000 | – | 55,600 | +100.0% | 0.02% | – | |
| New | PIXELWORKS INCcall | $12,000 | – | 12,800 | +100.0% | 0.01% | – | |
| New | BIOMARIN PHARMACEUTICAL INCcall | $13,000 | – | 4,500 | +100.0% | 0.01% | – | |
| New | TALEND S Acall | $5,000 | – | 15,100 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AIRGAIN ORD | 25 | Q3 2023 | 1.8% |
| PIXELWORKS ORD | 23 | Q3 2022 | 1.3% |
| SILICOM ORD | 22 | Q3 2023 | 1.8% |
| DSP GROUPS INC | 20 | Q3 2021 | 1.4% |
| DIGITAL TURBINE ORD | 19 | Q2 2023 | 1.0% |
| BK OF AMERICA CORP | 17 | Q3 2023 | 1.1% |
| EQUITY COMWLTH REIT ORD | 17 | Q3 2023 | 0.7% |
| ISHARES TR | 16 | Q4 2020 | 3.0% |
| SCPHARMACEUTICALS ORD | 16 | Q3 2023 | 2.8% |
| SELECT SECTOR SPDR TR | 16 | Q4 2020 | 1.3% |
View Worth Venture Partners, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Worth Venture Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.